Sentence examples for most profitable drug from inspiring English sources

"Subutex is the most profitable drug.

MEXICO CITY — Internal documents from one of Mexico's largest and most profitable drug trafficking cartels help explain why the group's leader remains at large, nearly a decade after he boldly escaped from a maximum-security prison by hiding in a laundry cart.

The most profitable drug in the world, Mr Isaly believes, will be one that treats Alzheimer's; and its launch may not be many years away.Having a bunch of drug behemoths on top of the market may not be good news for Wall Street's investment bankers.

Merck & Company's decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company.

Clinton would also prohibit "pay for delay" agreements, which allow major pharmaceutical companies to pay other drug companies to slow down production of cheaper versions of their most profitable drugs.

Bayer A.G. yesterday abruptly postponed its plan to list its shares on the New York Stock Exchange, citing its worsening situation in the wake of its decision to withdraw one of it most profitable drugs from the market.

The deal, which had been expected, could help Bristol-Myers plug gaps in its pharmaceutical portfolio as the patents for several of its most profitable drugs begin to expire.

It fears the loss of revenues from Lipitor, a cholesterol-lowering agent that is one of the world's most profitable drugs, and which Pfizer was marketing jointly with Warner-Lambert.

He and his staff have also intervened with nations including Turkey and Norway to defend Eli Lilly & Company, an Indiana-based pharmaceutical company whose employees are major contributors to Mr. Lugar's own political campaigns, against plans to introduce generic versions of some of its most profitable drugs, the documents show.

The Jan . 19ruling reassured investors that drug companies' patents will be protected from rivals that make slightly different versions of the their most profitable drugs.

The New York-based drugmaker (1997 sales, $17 billion) has, against all odds, preserved a near-monopoly over one of its most profitable drugs.